MedMen Enterprises, Inc.
MMNFF
4
|
$0.001
1440.0%
150K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-93.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-87.79% volume)
Earnings Calendar:
Market Cap: $ 500,344
http://www.medmen.com
Sec Filling | Patents | n/a employees
(US) MedMen Enterprises, Inc. engages in the cultivation, production, and retailing of cannabis supply chain. It operates growing and manufacturing facilities which use agronomic technology and sustainable techniques. The company was founded by Adam Bierman and Andrew Modlin in 2010 and is headquartered in Culver City, CA.
cannabis
add to watch list Paper trade email alert is off
Algernon Pharmaceuticals Inc.
AGNPF
|
$0.0708
178.69%
1.3K
|
Health Technology
(0.0% 1d) (12.0% 1m) (-57.3% 1y) (0.0% 2d) (0.0% 3d) (17.3% 7d) (4336.0% volume)
Earnings Calendar:
Market Cap: $ 1,532,166
http://www.algernonpharmaceuticals.com
Sec Filling | Patents | n/a employees
(CA) Algernon Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the development of repurposed therapeutic drugs. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, and idiopathic pulmonary fibrosis. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
urea kidney diseases kidney
add to watch list Paper trade email alert is off
Avricore Health Inc.
AVCRF
|
$0.069
207.83%
18K
|
Health Technology
(0.0% 1d) (-38.3% 1m) (-70.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-82.0% volume)
Earnings Calendar:
Market Cap: $ 6,887,557
http://www.avricorehealth.com
Sec Filling | Patents | n/a employees
(CA) Avricore Health, Inc. engages in the manufacture and distribution of generic and over-the-counter (OTC) pharmaceutical products. It firm operates through the Products and Point of Care business division. The Products business division offers OTC pharmaceutical through its Corozon platform. The Point of Care business division provides point of care screening services through its HealthTab system and software platform. Its products include Hema-fer, Cortivera, and Sennace. The company was founded on May 30, 2000 and is headquartered in Vancouver, Canada.
3d
add to watch list Paper trade email alert is off
ASTRAZENECA PLC
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
(0.0% 1d) (4.0% 1m) (-10.2% 1y) (0.0% 2d) (0.0% 3d) (0.2% 7d) (51.89% volume)
Earnings Calendar:
Market Cap: $ 211,946,254,525
http://astrazeneca.com
Sec Filling | Patents | n/a employees
(GB) AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
respiratory urea metabolic cardiovascular
add to watch list Paper trade email alert is off
BetterLife Pharma Inc.
BETRF
|
$0.0721
-3.71%
15K
|
Health Technology
(0.0% 1d) (-5.9% 1m) (20.7% 1y) (0.0% 2d) (-12.5% 3d) (-5.4% 7d) (-96.33% volume)
Earnings Calendar:
Market Cap: $ 8,206,804
http://abetterlifepharma.com
Sec Filling | Patents | n/a employees
(CA) BetterLife Pharma, Inc. is an early stage pharmaceutical company, which engages in the development and commercialization of therapeutic pharmaceutical and nutraceutical products. It also offers drug delivery platform technologies. Its product lines include capsules, tablets, and softgels; bulk powder; stick packs; beverages; oral solutions; lotions, creams, and gels; pet food additives; gum, mints, and candies; and sexual health products. It distributes its product under the Pivot Naturals brand. The company was founded on June 10, 2002 and is headquartered in Vancouver, Canada.
brands pets
add to watch list Paper trade email alert is off
Grown Rogue International Inc.
GRUSF
|
$0.66
-27.42%
260K
|
Health Technology
(0.0% 1d) (39.1% 1m) (374.1% 1y) (-3.0% 2d) (-5.9% 3d) (-5.9% 7d) (-54.67% volume)
Earnings Calendar:
Market Cap: $ 131,264,755
http://www.grownrogue.com
Sec Filling | Patents | n/a employees
(CA) Grown Rogue International, Inc. operates as a seed to experience cannabis brand. Its products include flower, pre-rolls, cartridges, and extracts, including shatter, wax, oil and sugar, which are categorized according to desired user experiences: relax, optimize, groove, uplift and energize. The company was founded on November 30, 2009 and is headquartered in Toronto, Canada.
brands msa seeds cannabis 3d optical
add to watch list Paper trade email alert is off
Intellipharmaceutics International Inc.
IPCIF
|
$0.07
-29.49%
4.2K
|
Health Technology
(0.0% 1d) (-26.3% 1m) (9.1% 1y) (0.0% 2d) (0.0% 3d) (-55.6% 7d) (-37.58% volume)
Earnings Calendar:
Market Cap: $ 2,316,487
http://www.intellipharmaceutics.com
Sec Filling | Patents | n/a employees
(CA) Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.
gastrointestinal urea diabetic diabetes cardiovascular
add to watch list Paper trade email alert is off
JUVA LIFE INC./Canada
JUVAF
|
$0.0262
-4.98%
7.6K
|
Health Technology
(0.0% 1d) (26.6% 1m) (-59.9% 1y) (0.0% 2d) (-33.3% 3d) (-23.8% 7d) (-14.01% volume)
Earnings Calendar:
Market Cap: $ 3,303,457
http://www.juvalife.com
Sec Filling | Patents | n/a employees
(CA) Juva Life, Inc. engages in the cultivation, manufacturing, research and development, distribution and retail of medical and recreational cannabis. It division includes Juva Cultivation, Juva Research, Juva Manufacturing, Juva Distribution, Juva Retail, and Juva Delivery. The Juva Retail is a network of retail cannabis facilities that will serve the San Francisco Bay Area. The Juva Research is Juva's therapeutics division which, when operational, will be involved in medicinal cannabis-based product research. The Juva Manufacturing will create Juva branded and white-label products for other recreational and medical related cannabis companies. The Juva Distribution will distribute Juva branded products and products from other licensed cannabis companies. The company was founded on April 3, 2019 and is headquartered in Vancouver, Canada.
brands cannabis urea
add to watch list Paper trade email alert is off
MEDICURE INC
MCUJF
|
$0.7943
0%
13K
|
Health Technology
(0.0% 1d) (-9.4% 1m) (-16.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (8500.0% volume)
Earnings Calendar:
Market Cap: $ 8,289,563
http://www.medicure.com
Sec Filling | Patents | n/a employees
(CA) Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of cardiovascular therapeutics. It focuses on the marketing and distribution of its acute care cardiovascular drug, AGGRASTAT; ZYPITAMAG (pitavastatin) tablets and the ReDS device in the United States. The company was founded by Albert D. Friesen on September 15, 1997 and is headquartered in Winnipeg, Canada.
cardiovascular
add to watch list Paper trade email alert is off
NOVO NORDISK A S
NONOF
|
$122.806
0.31%
5.1K
|
Health Technology
(0.0% 1d) (-5.4% 1m) (-29.0% 1y) (0.0% 2d) (-1.3% 3d) (-1.2% 7d) (-78.31% volume)
Earnings Calendar:
Market Cap: $ 421,661,962,043
http://www.novonordisk.com
Sec Filling | Patents | n/a employees
(DK) Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.
hormone diabetic diabetes insulin
add to watch list Paper trade email alert is off
NOVARTIS AG
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
(0.0% 1d) (-2.9% 1m) (12.4% 1y) (0.0% 2d) (-0.5% 3d) (0.0% 7d) (16233.33% volume)
Earnings Calendar:
Market Cap: $ 204,101,522,320
http://www.novartis.com
Sec Filling | Patents | n/a employees
(CH) Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
add to watch list Paper trade email alert is off
Predictmedix Inc.
PMEDF
|
$0.0285
-5.13%
35K
|
Health Technology
(0.0% 1d) (-41.3% 1m) (-73.3% 1y) (-33.3% 2d) (-33.3% 3d) (-26.7% 7d) (-97.17% volume)
Earnings Calendar:
Market Cap: $ 4,282,397
http://www.predictmedix.com
Sec Filling | Patents | n/a employees
(CA) Predictmedix, Inc. is an artificial intelligence company. It is engaged in developing disruptive tools for impairment testing and healthcare. The firm's subsidiaries are in the early stage marijuana services and products, development of cosmetic and edible product lines, as well as investment in technology to detect if an individual is under the influence of cannabis and to predict substance addiction. The company was founded on September 3, 1987 and is headquartered in Toronto, Canada.
cannabis artificial intelligence
add to watch list Paper trade email alert is off
SERNOVA CORP.
SEOVF
|
$0.3295
15.67%
29K
|
Health Technology
(0.0% 1d) (-19.4% 1m) (-45.9% 1y) (0.0% 2d) (0.0% 3d) (-3.0% 7d) (225.0% volume)
Earnings Calendar:
Market Cap: $ 99,972,833
http://www.sernova.com
Sec Filling | Patents | n/a employees
(CA) Sernova Corp. is a clinical stage regenerative medicine company. It engages in the business of developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins and hormones missing within the body. The firm also focuses in the manufacture and clinical evaluation of the cell pouch for insulin-dependent diabetes. The company was founded in 1992 and is headquartered in London, Canada.
metabolic hormone t-cell treatment diabetic diabetes ceiling insulin
add to watch list Paper trade email alert is off
Sagimet Biosciences Inc.
SGMT | $4.0 0.76% 0.75% 430K
|
Health Technology
(0.0% 1d) (-13.8% 1m) (-74.9% 1y) (1.0% 2d) (-1.5% 3d) (-12.1% 7d) (27.48% volume)
Earnings Calendar:
Market Cap: $ 121,573,588
https://sagimet.com/
Sec Filling | Patents | 6 employees
(United States) in march of 1963, a one-man pool supply operation working out of a backyard shed in north hollywood, california, began. that journey continues today - 50 years later - as leslie's poolmart, inc., “the world’s largest retailer of swimming pool supplies” . with over 850 retail stores in 35 states across america, plus the availability of commercial sales, mail order and internet shopping, leslie ’s offers every customer the ultimate experience. leslie’s offers a comprehensive product line including chemicals, cleaning devices, equipment, parts, recreational and safety products, as well as many unique items for the backyard and patio. we also offer professional on-site equipment installation and repair services in most areas. leslie’s is the best place to find everything you need to make owning a swimming pool and spa fun and easy, at the best prices guaranteed. but we’re so much more than just great products at great prices. our highly trained staff of pool professionals provide you w
add to watch list Paper trade email alert is off
Sanofi
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
(0.0% 1d) (-2.7% 1m) (-16.9% 1y) (0.0% 2d) (0.0% 3d) (-0.3% 7d) (41938.42% volume)
Earnings Calendar:
Market Cap: $ 114,818,843,686
http://www.sanofi.com
Sec Filling | Patents | n/a employees
(FR) Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
vaccine diabetic diabetes cardiovascular
add to watch list Paper trade email alert is off
Tyra Biosciences, Inc.
TYRA | $14.93 1.84% 1.81% 220K
|
Health Technology
(0.0% 1d) (-10.5% 1m) (4.0% 1y) (0.0% 2d) (3.7% 3d) (1.6% 7d) (95.17% volume)
Earnings Calendar: 2024-03-21
Market Cap: $ 784,139,277
https://tyra.bio
Sec Filling | Patents | 2021 employees
Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra is using its proprietary SNÅP platform, which is optimized to enable rapid and precise refinement of structural design through iterative molecular SNÅPshots, in order to generate next-generation product candidates that are specifically designed to address acquired drug resistance and provide alternative treatment options. Tyra is initially focused on developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor, or FGFR, family, which are altered in approximately 7% of all cancers. Tyra's lead product candidate, TYRA-300, is designed to selectively inhibit FGFR3, with an initial focus on patients with bladder cancer.
treatment cancer optical
add to watch list Paper trade email alert is off
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10